{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:24:41Z","timestamp":1649035481325},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","revespcardiol.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.rec.2018.06.012","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T14:29:56Z","timestamp":1531924196000},"page":"500-502","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subcutaneous Furosemide in Patients With Refractory Heart Failure"],"prefix":"10.1016","volume":"72","author":[{"given":"Ainara","family":"Lozano Bahamonde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Escolar P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Echebarria Chousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Azcona Lucio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Alfambra Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Rodr\u00edguez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2018.06.012_bib0025","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0269216311399490","article-title":"Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?","volume":"25","author":"Zacharias","year":"2011","journal-title":"Palliat Med."},{"key":"10.1016\/j.rec.2018.06.012_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/bmjspcare-2011-000199","article-title":"Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base?","volume":"2","author":"Beattie","year":"2012","journal-title":"BMJ Support Palliat Care."},{"key":"10.1016\/j.rec.2018.06.012_bib0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.recesp.2013.06.010","article-title":"Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience","volume":"66","author":"Zatarain-Nicol\u00e1s","year":"2013","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2018.06.012_bib0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2017.10.001","article-title":"Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure","volume":"6","author":"Gilotra","year":"2018","journal-title":"JACC Hear Fail."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585718302524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585718302524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:46:52Z","timestamp":1559220412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585718302524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1885585718302524"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2018.06.012","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous Furosemide in Patients With Refractory Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2018.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2018.04.031","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}